OPKO Health Return on Tangible Equity 2010-2023 | OPK
OPKO Health Return On Tangible Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
2023-12-31 | $-0.19B | $0.05B | -167.11% |
2023-09-30 | $-0.21B | $0.09B | -153.05% |
2023-06-30 | $-0.21B | $0.16B | -124.96% |
2023-03-31 | $-0.29B | $0.15B | -147.16% |
2022-12-31 | $-0.33B | $0.14B | -155.27% |
2022-09-30 | $-0.32B | $0.22B | -82.02% |
2022-06-30 | $-0.20B | $0.28B | -40.75% |
2022-03-31 | $-0.12B | $0.21B | -19.96% |
2021-12-31 | $-0.03B | $0.84B | -4.47% |
2021-09-30 | $0.08B | $0.66B | 12.90% |
2021-06-30 | $0.07B | $0.62B | 13.14% |
2021-03-31 | $0.12B | $0.56B | 24.69% |
2020-12-31 | $0.03B | $0.52B | 7.04% |
2020-09-30 | $-0.11B | $0.46B | -27.23% |
2020-06-30 | $-0.20B | $0.42B | -50.38% |
2020-03-31 | $-0.29B | $0.37B | -73.71% |
2019-12-31 | $-0.32B | $0.41B | -74.51% |
2019-09-30 | $-0.28B | $0.38B | -63.63% |
2019-06-30 | $-0.25B | $0.43B | -53.96% |
2019-03-31 | $-0.19B | $0.47B | -41.61% |
2018-12-31 | $-0.15B | $0.48B | -33.91% |
2018-09-30 | $-0.30B | $0.44B | -66.63% |
2018-06-30 | $-0.30B | $0.45B | -61.03% |
2018-03-31 | $-0.31B | $0.44B | -57.04% |
2017-12-31 | $-0.31B | $0.44B | -50.58% |
2017-09-30 | $-0.13B | $0.66B | -19.23% |
2017-06-30 | $-0.10B | $0.66B | -16.22% |
2017-03-31 | $-0.07B | $0.65B | -11.74% |
2016-12-31 | $-0.05B | $0.62B | -8.03% |
2016-09-30 | $-0.01B | $0.62B | -1.52% |
2016-06-30 | $0.13B | $0.52B | 23.39% |
2016-03-31 | $0.08B | $0.63B | 13.54% |
2015-12-31 | $-0.03B | $0.60B | -5.66% |
2015-09-30 | $-0.09B | $0.55B | -16.43% |
2015-06-30 | $-0.26B | $0.44B | -49.46% |
2015-03-31 | $-0.24B | $0.53B | -42.55% |
2014-12-31 | $-0.17B | $0.55B | -29.95% |
2014-09-30 | $-0.14B | $0.60B | -23.45% |
2014-06-30 | $-0.15B | $0.62B | -25.67% |
2014-03-31 | $-0.13B | $0.53B | -27.41% |
2013-12-31 | $-0.12B | $0.57B | -31.81% |
2013-09-30 | $-0.10B | $0.57B | -44.59% |
2013-06-30 | $-0.05B | $0.15B | -58.68% |
2013-03-31 | $-0.06B | $0.16B | -104.59% |
2012-12-31 | $-0.03B | $0.01B | -120.39% |
2012-09-30 | $-0.01B | $0.01B | -36.09% |
2012-06-30 | $-0.01B | $0.04B | -21.89% |
2012-03-31 | $-0.01B | $0.04B | -9.52% |
2011-12-31 | $-0.00B | $0.04B | -3.87% |
2011-09-30 | $-0.02B | $0.08B | -31.88% |
2011-06-30 | $-0.02B | $0.09B | -42.42% |
2011-03-31 | $-0.02B | $0.10B | -60.27% |
2010-12-31 | $-0.02B | $0.01B | -96.55% |
2010-09-30 | $-0.03B | $0.00B | -133.33% |
2010-06-30 | $-0.03B | $0.03B | -88.89% |
2010-03-31 | $-0.03B | $0.04B | -87.32% |
2009-12-31 | $-0.04B | $0.01B | -159.09% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.878B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $218.951B | 26.53 |
Intuitive Surgical (ISRG) | United States | $133.132B | 80.20 |
Edwards Lifesciences (EW) | United States | $52.025B | 33.89 |
DexCom (DXCM) | United States | $49.242B | 74.90 |
IQVIA Holdings (IQV) | United States | $42.631B | 25.28 |
IDEXX Laboratories (IDXX) | United States | $41.469B | 49.58 |
Alcon (ALC) | Switzerland | $38.841B | 28.64 |
STERIS (STE) | Ireland | $20.148B | 23.85 |
Waters (WAT) | United States | $18.463B | 26.49 |
Hologic (HOLX) | United States | $17.835B | 19.68 |
SONOVA HOLDING (SONVY) | Switzerland | $16.800B | 0.00 |
ShockWave Medical (SWAV) | United States | $12.341B | 85.27 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.795B | 14.57 |
Sysmex ADR (SSMXY) | Japan | $10.000B | 31.36 |
Teleflex (TFX) | United States | $9.736B | 15.29 |
Penumbra (PEN) | United States | $7.923B | 97.80 |
Masimo (MASI) | United States | $7.204B | 40.40 |
Globus Medical (GMED) | United States | $6.843B | 21.70 |
Glaukos (GKOS) | United States | $4.993B | 0.00 |
Integer Holdings (ITGR) | United States | $3.671B | 22.18 |
TransMedics (TMDX) | United States | $3.012B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.996B | 19.76 |
PROCEPT BioRobotics (PRCT) | United States | $2.664B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.629B | 18.04 |
Nihon Kohden (NHNKY) | Japan | $2.417B | 20.44 |
Tandem Diabetes Care (TNDM) | United States | $2.275B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $2.228B | 9.14 |
Inari Medical (NARI) | United States | $2.227B | 384.20 |
RxSight (RXST) | United States | $1.952B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.716B | 0.00 |
Veracyte (VCYT) | United States | $1.450B | 0.00 |
Artivion (AORT) | United States | $0.847B | 97.95 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.836B | 15.47 |
Paragon 28 (FNA) | United States | $0.730B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.720B | 0.00 |
Silk Road Medical (SILK) | United States | $0.697B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.642B | 0.00 |
SiBone (SIBN) | United States | $0.598B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.557B | 18.90 |
IRadimed (IRMD) | United States | $0.530B | 30.78 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.486B | 0.00 |
Nevro (NVRO) | United States | $0.415B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.397B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.394B | 0.00 |
NeuroPace (NPCE) | United States | $0.385B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.340B | 11.44 |
CVRx (CVRX) | United States | $0.317B | 0.00 |
AxoGen (AXGN) | United States | $0.290B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.270B | 0.00 |
Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
AngioDynamics (ANGO) | United States | $0.233B | 0.00 |
Accuray (ARAY) | United States | $0.217B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.192B | 0.00 |
908 Devices (MASS) | United States | $0.187B | 0.00 |
Semler Scientific (SMLR) | United States | $0.184B | 9.89 |
Alpha Tau Medical (DRTS) | Israel | $0.168B | 0.00 |
Inogen (INGN) | United States | $0.160B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.142B | 0.00 |
Delcath Systems (DCTH) | United States | $0.135B | 0.00 |
Neuronetics (STIM) | United States | $0.105B | 0.00 |
Envoy Medical (COCH) | United States | $0.102B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.100B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
Hyperfine (HYPR) | United States | $0.061B | 0.00 |
SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.056B | 113.67 |
Vasomedical (VASO) | United States | $0.053B | 9.47 |
Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
InspireMD (NSPR) | Israel | $0.047B | 0.00 |
DarioHealth (DRIO) | United States | $0.044B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.041B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
LENSAR (LNSR) | United States | $0.037B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.033B | 0.00 |
Spectral AI (MDAI) | United States | $0.032B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
PAVmed (PAVM) | United States | $0.016B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.016B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
Nuwellis (NUWE) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |